ASC Billing Services · CY2026

What Landed on the 2026 ASC Covered Procedures List, and the 90-Day Clock That Starts the Day You Bill It

Short answer: CMS moved hundreds of procedures onto the 2026 ASC Covered Procedures List in the CY2026 OPPS/ASC Final Rule (CMS-1834-FC), and it began phasing out the Inpatient Only list. A lot of what migrated is musculoskeletal. The day you bill one of those new codes, three clocks start at once, charge master, device offset, and quality reporting, and most ASCs only notice the first one.

CMS-1834-FCCY2026 OPPS/ASC Final Rule
2.6%ASC rate update, ASCQR-tied
≥30%Device-intensive threshold
90 daysOur reconciliation window

The trap in one line

A new covered procedure is not a solved procedure

When CMS adds a code to the ASC-CPL, your scheduler can book it and your surgeon can perform it. Neither of those events tells your charge master, your device-mapping table, or your ASCQR abstraction queue that anything changed. So the case goes out the door billed like last year's case, and the underpayment or the packaging denial shows up 45 days later when nobody remembers why. Here is the full timeline, node by node.

01
Nov 2025 · Rule drops
CMS adds the code to the ASC-CPL

The CY2026 OPPS/ASC Final Rule (CMS-1834-FC) revised the CPL eligibility criteria and moved a large block of surgical procedures onto the list, alongside the start of the Inpatient Only list phase-out. Cardiac and musculoskeletal cases are prominent in what became ASC-eligible.

The authoritative source is the ASC addenda (Addendum AA for surgical, Addendum BB for covered ancillary), not a press summary. Pull the addenda and diff them against your 2025 fee schedule.

Addendum AA / BBIPO phase-out
02
Before first case · The miss
Your charge master still reflects last year

This is where ASCs that added migrated MSK cases lose money quietly. The CDM was built for the cases you did in 2024. A newly covered arthroscopy, fusion, or joint procedure has a payable ASC rate now, but if the code was never loaded, or was loaded at a legacy price, or is mapped to the wrong revenue code, the claim can go out under-charged or get packaged incorrectly.

Migrated procedures are the highest-risk group precisely because they feel familiar to the OR and brand-new to the billing system.

Charge master gapWrong rev code
03
Claim build · Packaging
Device-intensive designation and the offset

Many migrated MSK and cardiac procedures carry a device-intensive designation, meaning the device cost is at least 30% of the procedure's mean cost. For those codes, ASC payment is built around the device offset rather than the standard ASC reduction, so the implant is not a throwaway line, it is most of the payment.

Two failure modes cost real dollars: forgetting the device HCPCS on a device-intensive claim, and forgetting FB/FC when the device came at no cost or with a credit. The first leaves money on the table; the second is a compliance exposure.

Modifier FBModifier FCDevice HCPCS
04
Day 0 · The clock starts
You bill it, and the 90-day window opens

Medicare's timely-filing limit is one calendar year from the date of service, so nothing forces urgency on paper. That is exactly the problem. We treat the first billed instance of any newly covered procedure as Day 0 of a 90-day reconciliation clock, our operating cadence, not a CMS deadline, because 90 days is long enough to see the first remittances and short enough to fix the CDM before the volume compounds.

Inside that window you confirm three things landed: the rate paid, the device offset paid, and the claim cleared without a packaging edit.

1-yr timely filing90-day CDM audit
05
Same year · Quality
ASCQR is now attached to this case too

The 2.6% CY2026 payment update only applies to ASCs that meet ASC Quality Reporting (ASCQR) requirements. New covered procedures widen the population your measures are drawn from, so they have to be inside your abstraction and submission workflow from the first case, not bolted on at year-end.

Keep the live measure set in view: the OAS CAHPS survey measures, the post-procedure hospital-visit outcome measures, COVID-19 HCP vaccination (ASC-20), and the health-equity and social-drivers measures phased in through recent rules. Claims-based measures ride on the same claims you are already fixing in nodes 2 and 3, which is why quality and revenue integrity are the same project here.

ASCQROAS CAHPSASC-20
06
By day 90 · Close the loop
Reconcile, or repeat the leak on every future case

The window closes with a three-way check: expected ASC rate vs paid, device offset expected vs paid, and zero unresolved packaging or ASCQR gaps on the code. Anything that fails becomes a CDM correction and a note in your annual addenda review, so next January's additions do not reopen the same hole.

Rate reconciliationOffset audit

Migrated MSK, side by side

Same procedure, two ways it leaves your ASC

Archetype: a mid-volume orthopedic ASC that added several MSK cases newly covered under the 2026 CPL and started scheduling them in January. Nothing below is client-specific; it is the pattern we see when the charge master lags the addenda.

CheckpointBilled on stale CDMBilled on updated CDM
Code loaded to CPL× not on fee schedule✓ loaded from Addendum AA
Device HCPCS on claim× implant line missing✓ device coded, offset intact
No-cost device handling× FB/FC omitted✓ FB/FC applied when credited
ASCQR capture× case outside abstraction✓ in the measure workflow
Result by day 90underpaid, packaging denialsclean pay, offset honored
One diff prevents most of this.

Diff the CY2026 ASC Addendum AA against your live fee schedule, flag every added code you actually perform, and confirm each one has a rate, a device mapping, and a place in your ASCQR workflow before the first case bills. That single reconciliation is cheaper than a quarter of underpayments.

We run the 90-day clock so your ASC does not find the leak in April

ASP-RCM's ASC billing team reconciles your charge master to the CY2026 addenda, protects device-intensive payments and FB/FC handling, and keeps new covered procedures inside your ASCQR reporting from case one. You keep the 2.6% update and the full offset instead of chasing them later.

Map your 2026 CPL additions with us
ASP-RCM Solutions · Senior Partner, Frisco

Guidelines referenced

  • CMS CY2026 Medicare OPPS & ASC Payment System Final Rule (CMS-1834-FC), including the revised ASC Covered Procedures List criteria and the Inpatient Only list phase-out
  • ASC Covered Procedures List, Addendum AA (surgical) and Addendum BB (covered ancillary services)
  • ASC device-intensive procedure designation (device cost at least 30% of the procedure's mean cost) and device-offset packaging, including no-cost and reduced-cost device modifiers FB and FC
  • ASC Quality Reporting (ASCQR) Program measures, including OAS CAHPS survey measures, post-procedure hospital-visit outcome measures, ASC-20 COVID-19 HCP vaccination, and the social-drivers and health-equity measures phased in through recent rulemaking; CY2026 2.6% payment update is contingent on ASCQR compliance
  • Medicare claims timely-filing limit of one calendar year from the date of service

Related reading

More on this topic

Field note

The second line is where ASC money quietly leaks.

How the ASC 50% multiple-procedure reduction and modifiers 50, 51, 59, 73, and 74 change the actual paid amoun

Read →Case study

Total joints moved outpatient. Your billing has to move with them.

A vertical-timeline operator's guide to moving total hip and knee arthroplasty into the ASC: sequencing the bi

Read →Briefing

How the 2.4% lands

CMS-1850-P, issued July 2, 2026, proposes a 2.4% OPPS and ASC payment update, continued Inpatient Only list ph

Read →